AKR1C2 also metabolizes carcinogens and reduces ROS levels in cancer cells, thereby enhancing their tolerance to oxidative stress and drug stimuli and is abnormally expressed in various tumors (Li et al., 2023; Wang et al., 2023). This evidence concerns the gene AKR1C2 and cancer.